Global Pharmacovigilance and Drug Safety Software Market

Global Pharmacovigilance and Drug Safety Software Market Overview

• The Global Pharmacovigilance and Drug Safety Software Market Size is Expected to Grow from 9.41 Billion in 2023 to USD 22.71 Billion by 2033, at a CAGR of 9.21% during the forecast period 2023-2033.
• The expanding market for drug safety and pharmacovigilance software. Advanced software solutions are required to adequately monitor and manage potential risks due to the complexity of medications and medical equipment.
• Ensuring patient safety is becoming more and more crucial as new medications are developed, making the employment of powerful software tools to identify and handle adverse events as they arise necessary.

Major vendors in the Global Pharmacovigilance and Drug Safety Software Market

• IQVIA Holdings, Cognizant, ICON plc, PAREXEL International, Accenture, IBM, Wipro, Take Solutions, Tata Consultancy Services (TCS), Capgemini, and others.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the pharmacovigilance and drug safety software market based on the below-mentioned segments:

Global Pharmacovigilance and Drug Safety Software Market, By Functionality

• Adverse Event Reporting Software
• Signal Management Software

Global Pharmacovigilance and Drug Safety Software Market, By Deployment Mode

• On-premise
• Cloud

Global Pharmacovigilance and Drug Safety Software Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa